SEC Form D private-offering filing

ThirdLaw Molecular, Inc.

A new SEC Form D private-offering notice from Blue Bell, PA, a $5,500,000 filer-stated offering target in Biotech. The source filing is one click away.

ThirdLaw Molecular, Inc. site↗ Verified via SEC Form D

Biotechnology company (recently rebranded Ladder Bio) developing Spiroligomer therapeutics: ladder shaped peptide like molecules designed to engage difficult biological targets, spun out of Temple University research.

Filed 2025-10-08Filed to raise $5,500,000First money in 2025-09-02Raised so far $5,500,000HQ (as filed) Blue Bell, PASector Biotech ✓Stage (inferred) EarlyCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified ladderbio.com↗Named in the filing 4 executives & directors
Open this row on the live feed →More new filings in Pennsylvania →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.